BactoBots™ are synthetic biology engineered bacteria. These microscopic organisms can perform many activities to include releasing medically important chemicals and killing cancer cells. Shengchang Su, PhD, Li Guo, PhD, Ravi Samy, MD, FACS, and Kumaresh Krishnamoorthy, MD, are developing these technologies. The United States of America’s National Science Foundation (NSF) and Microbial Robotics funded BactoBots™ technology that, in vitro, demonstrates destroying cholesteatoma tumors as an adjunct, or replacement, to skull-based surgery.
Want to save these project details? Download this brief Project Manifest for your convenience!